1-2 of 2
Helmut Salih
Close
Sort by
Journal Articles

Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3A mut NPM1 mut AMLs

Elisa Donato, Nadia Correia, Carolin Andresen, Darja Karpova, Roberto Würth, Corinna Klein, Markus Sohn, Adriana Przybylla, Petra Zeisberger, Kathrin Rothfelder, Helmut Salih, Halvard Bonig, Sebastian Stasik, Christoph Röllig, Anna Dolnik, Lars Bullinger, Frank Buchholz, Christian Thiede, Daniel Hübschmann, Andreas Trumpp
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1011–1018.
https://doi.org/10.1182/bloodadvances.2022008497
Published: 2023
Includes: Supplemental data
Journal Articles

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

Clinical Trials & Observations
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5345–5355.
https://doi.org/10.1182/bloodadvances.2022007223
Published: 2022
Includes: Supplemental data